NY-ESO-1 in Triple-Negative Breast Cancer: Systematic Review, Meta-Analysis, and Immunotherapeutic Implications
International Immunopharmacology · 2026-05 · 177 · 116459
DOI: 10.1016/j.intimp.2026.116459 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Immunopharmacology, 2026-05. Verfasst von Nik Mohd Asri Nik Amirah Auni und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Antigens, Neoplasm, Immunotherapy, Membrane Proteins. Die Arbeit nennt 144 Literaturangaben. Gefördert von: Malaysia Ministry of Higher Education.
Abstract (Originalsprache)
Breast cancer remains one of the most common types of cancer, including the subtype triple-negative breast cancer (TNBC) which is challenging to treat due to its aggressiveness. Cancer-testis antigens (CTAs), especially New York Esophageal Squamous Cell Carcinoma 1 (NY-ESO-1), have become promising immunotherapeutic targets attributable to their restricted expression profile in normal tissues but overexpressed in TNBC, leading to immunogenicity. This review provides comprehensive discussion of NY-ESO-1 including its structural basis of NY-ESO-1 recognition by T cell receptors (TCRs) and antibodies, epigenetic regulation via DNA methylation or histone modifications, and expression patterns or clinical relevance in TNBC. A systematic meta-analysis of 12 studies comprising 1,545 TNBC patients showed a pooled NY-ESO-1 expression prevalence of 16.1% (95% CI: 11.4-22.2%), with heterogeneity (I2=83.7%) attributable to antibody clone used for NY-ESO-1 detection (E978: 15.1% vs. D8.38: 32.6%, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
- Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
- Department of Surgery, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.
- Tissue Bank Unit, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia; Department of Otorhinolaryngology-Head & Neck Surgery, School of Medical Sciences, Universiti Sains Malaysia, K…
- Department of Immunology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian, Kelantan, Malaysia. Electronic address: kahkeng@usm.my.
Förderung
- Malaysia Ministry of Higher Education
Zitieren
APA
Nik Amirah Auni, N. M. A., Mohd Redzwan, N., Hussain, F. A., Yahya, M. M., Ab Hamid, S. S., & Wong, K. K. (2026). NY-ESO-1 in Triple-Negative Breast Cancer: Systematic Review, Meta-Analysis, and Immunotherapeutic Implications. International Immunopharmacology, 177, 116459. https://doi.org/10.1016/j.intimp.2026.116459
Vancouver
Nik Amirah Auni NMA, Mohd Redzwan N, Hussain FA, Yahya MM, Ab Hamid SS, Wong KK. NY-ESO-1 in Triple-Negative Breast Cancer: Systematic Review, Meta-Analysis, and Immunotherapeutic Implications. International Immunopharmacology. 2026;177:116459. doi:10.1016/j.intimp.2026.116459
BibTeX
@article{NikAmirahAuni2026,
author = {Nik Amirah Auni, Nik Mohd Asri and Mohd Redzwan, Norhanani and Hussain, Faezahtul Arbaeyah and Yahya, Maya Mazuwin and Ab Hamid, Suzina Sheikh and Wong, Kah Keng},
title = {NY-ESO-1 in Triple-Negative Breast Cancer: Systematic Review, Meta-Analysis, and Immunotherapeutic Implications},
journal = {International Immunopharmacology},
year = {2026},
volume = {177},
pages = {116459},
doi = {10.1016/j.intimp.2026.116459}
}
EUVIMED